Evidence map›Paper›PMID 23140080›Full record

ArticleEthnicity & disease2012

Perception of generic prescription drugs and utilization of generic drug discount programs.

Anthony Omojasola, Mike Hernandez, Sujit Sansgiry, Lovell Jones

Abstract read
In one paragraph

Article in Ethnicity & disease, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 2 pooled it
7.1field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 2 syntheses or guidelines pooled it, 22 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Determinants of Generic Drug Substitution in the United States.Therapeutic innovation & regulatory science · 2020
    Article
  8. Article
  9. Article
  10. The Impact of Information on Doctors' Attitudes Toward Generic Drugs.Inquiry : a journal of medical care organization, provision and financing · 2016
    Article
  11. Consumers' perception of generic substitution in Iran.International journal of clinical pharmacy · 2015
    Article
  12. Article
  13. Observational
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Anthony OmojasolaDepartment of Health Disparities Research, The University of Texas MD Anderson Cancer Center, Houston, TX 77030-4009, USA. aomoja@aol.com
Mike Hernandez
Sujit Sansgiry
Lovell Jones
The University of Texas MD Anderson Cancer Center · USUniversity of Houston · US

Funding

SHARED RESOUCES COREP60MD000503 · NIMHD · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI JONES, LOVELL ALLAN · 2003 to 2011
$12.4M
NIMHD NIH HHS P60 MD000503
6 · The paper itself

Abstract

objectiveOur study aimed to assess patient's perceptions of generic drugs and utilization of generic drug discount programs. DESIGN, SETTING AND

participantsA survey was administered to adult participants at community health centers and community-based organizations in Houston, Texas, USA (n=525).

main outcome measuresMultivariate logistic regression was used to quantify the strength of association between generic drug perception and utilization of generic drug discount programs.

resultsRespondents who agreed that "Generic prescription drugs are as effective as brand name prescription drugs," were 3 times as likely to utilize generic drug discount programs (AOR: 3.0, 95% CI: 1.8-4.8, P<.001). Compared to non-Hispanic Whites, African Americans (OR: 10.2; 95% CI: 1.4-76.4) and Hispanics (OR: 10.3; 95% CI: 1.3-79.4) were 10 times as likely to agree that generic drugs have more side effects than brand name drugs.

conclusionRace/ethnicity had no impact in utilization of generic drug discount programs, despite racial disparities in perception toward generic drugs' side effects and generic drugs being inferior to brand name drugs.

Indexed as

AttitudeAdolescentAdultAgedCost SavingsCross-Sectional StudiesDrugs, GenericFemaleHealth Care CostsHealth Care SurveysHumansInsurance, Pharmaceutical ServicesLogistic ModelsMaleMiddle AgedPrescription DrugsDrugs, GenericPrescription Drugs

Identifiers

PMID23140080
PMCPMC3522080
OpenAlexW1862079173

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.